Literature DB >> 32088581

Microbe-microbe interactions during Clostridioides difficile infection.

Arwa Abbas1, Joseph P Zackular2.   

Abstract

Clostridioides difficile is the leading cause of hospital-acquired gastrointestinal infections and a major public health burden in the United States. C. difficile infection causes a spectrum of disease from mild diarrhea to severe complications such as pseudomembranous colitis, toxic megacolon and death. This broad range of disease is only partially explained by bacterial genetic factors, host genetics, comorbidities and previous drug exposures. Another important factor is the gut microbiome, the disruption of which results in a loss of colonization resistance to C. difficile. Here, we review how gut microbiota and their metabolites impact C. difficile virulence and influence disease.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32088581      PMCID: PMC7244385          DOI: 10.1016/j.mib.2020.01.016

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  62 in total

1.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

Authors:  Carles Ubeda; Ying Taur; Robert R Jenq; Michele J Equinda; Tammy Son; Miriam Samstein; Agnes Viale; Nicholas D Socci; Marcel R M van den Brink; Mini Kamboj; Eric G Pamer
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

3.  Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses.

Authors:  David Rojo; María J Gosalbes; Rafaela Ferrari; Ana E Pérez-Cobas; Ester Hernández; Rosa Oltra; Javier Buesa; Amparo Latorre; Coral Barbas; Manuel Ferrer; Andrés Moya
Journal:  ISME J       Date:  2015-03-10       Impact factor: 10.302

4.  Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.

Authors:  Jessica A Ferreyra; Katherine J Wu; Andrew J Hryckowian; Donna M Bouley; Bart C Weimer; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2014-12-10       Impact factor: 21.023

5.  Bile salt hydrolase-mediated inhibitory effect of Bacteroides ovatus on growth of Clostridium difficile.

Authors:  Soobin Yoon; Junsun Yu; Andrea McDowell; Sung Ho Kim; Hyun Ju You; GwangPyo Ko
Journal:  J Microbiol       Date:  2017-10-27       Impact factor: 3.422

6.  Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938.

Authors:  Paul A Lawson; Diane M Citron; Kerin L Tyrrell; Sydney M Finegold
Journal:  Anaerobe       Date:  2016-06-28       Impact factor: 3.331

Review 7.  Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.

Authors:  Maja Rupnik
Journal:  FEMS Microbiol Rev       Date:  2008-04-03       Impact factor: 16.408

8.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.

Authors:  Casey M Theriot; Mark J Koenigsknecht; Paul E Carlson; Gabrielle E Hatton; Adam M Nelson; Bo Li; Gary B Huffnagle; Jun Z Li; Vincent B Young
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

9.  Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.

Authors:  Alexa R Weingarden; Peter I Dosa; Erin DeWinter; Clifford J Steer; Megan K Shaughnessy; James R Johnson; Alexander Khoruts; Michael J Sadowsky
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

10.  An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection.

Authors:  Vijay C Antharam; Daniel C McEwen; Timothy J Garrett; Aaron T Dossey; Eric C Li; Andrew N Kozlov; Zhubene Mesbah; Gary P Wang
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

View more
  20 in total

Review 1.  From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis.

Authors:  Alexander B Smith; Joshua Soto Ocana; Joseph P Zackular
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

2.  An Unusual Presentation of Clostridioides Difficile Colitis in a Patient on Opioids.

Authors:  Oluwafemi A Ajibola; Taiwo O Aremu; Sikder Hassan; Nili Gujadhur; Valerie Cluzet
Journal:  Cureus       Date:  2022-05-29

3.  Effect of cryopreservation medium conditions on growth and isolation of gut anaerobes from human faecal samples.

Authors:  Anaïs Biclot; Geert R B Huys; Rodrigo Bacigalupe; Kevin D'hoe; Doris Vandeputte; Gwen Falony; Raul Y Tito; Jeroen Raes
Journal:  Microbiome       Date:  2022-05-30       Impact factor: 16.837

Review 4.  Clostridioides difficile and the Microbiota Early in Life.

Authors:  Alexa K Semon; Orlaith Keenan; Joseph P Zackular
Journal:  J Pediatric Infect Dis Soc       Date:  2021-11-17       Impact factor: 5.235

Review 5.  Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.

Authors:  Shannon L Kordus; Audrey K Thomas; D Borden Lacy
Journal:  Nat Rev Microbiol       Date:  2021-11-26       Impact factor: 78.297

6.  Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection.

Authors:  Giovanny Herrera; Laura Vega; Manuel Alfonso Patarroyo; Juan David Ramírez; Marina Muñoz
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

7.  Unexpected Results From a Phase 2 Trial of a Microbiome Therapeutic for Clostridioides difficile Infection: Lessons for the Future.

Authors:  Vincent Bensan Young
Journal:  Clin Infect Dis       Date:  2020-04-24       Impact factor: 9.079

Review 8.  Polymicrobial Interactions Operative during Pathogen Transmission.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

9.  Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease.

Authors:  Frederic D Bushman; Maire Conrad; Yue Ren; Chunyu Zhao; Christopher Gu; Christopher Petucci; Min-Soo Kim; Arwa Abbas; Kevin J Downes; Nina Devas; Lisa M Mattei; Jessica Breton; Judith Kelsen; Sarah Marakos; Alissa Galgano; Kelly Kachelries; Jessi Erlichman; Jessica L Hart; Michael Moraskie; Dorothy Kim; Huanjia Zhang; Casey E Hofstaedter; Gary D Wu; James D Lewis; Joseph P Zackular; Hongzhe Li; Kyle Bittinger; Robert Baldassano
Journal:  Cell Host Microbe       Date:  2020-08-20       Impact factor: 31.316

10.  Metabolic adaption to extracellular pyruvate triggers biofilm formation in Clostridioides difficile.

Authors:  Yannick D N Tremblay; Benjamin A R Durand; Audrey Hamiot; Isabelle Martin-Verstraete; Marine Oberkampf; Marc Monot; Bruno Dupuy
Journal:  ISME J       Date:  2021-06-21       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.